Showing results (111-120 of 130) with videos related to
Sort By:
Pageof 13
The Journal of Pharmacology and Experimental Therapeutics|February 12, 1998
Ro 61-1790, a new hydrosoluble endothelin antagonist: general pharmacology and effects on experimental cerebral vasospasmS Roux, V Breu, T Giller, et al.Hypertension (Dallas, Tex. : 1979)|September 1, 1996
Endothelin antagonism in end-organ damage of spontaneously hypertensive rats. Comparison with angiotensin-converting enzyme inhibition and calcium antagonismH Karam, D Heudes, P Bruneval, et al.Blood|April 15, 1993
Relationship between tissue factor expression and deposition of fibrin, platelets, and leukocytes on cultured endothelial cells under venous blood flow conditionsD Kirchhofer, K S Sakariassen, M Clozel, et al.Cardiovascular Research|February 1, 1996
Respective role of humoral factors and blood pressure in cardiac remodeling of DOCA hypertensive ratsH Karam, D Heudes, P Hess, et al.Hypertension (Dallas, Tex. : 1979)|August 1, 1995
Effects of human renin in the vasculature of rats transgenic for human angiotensinogenD N Müller, K F Hilgers, J Bohlender, et al.Circulation Research|January 24, 1998
Local angiotensin II generation in the rat heart: role of renin uptakeD N Müller, W Fischli, J P Clozel, et al.Cell and Tissue Research|February 27, 1999
The endothelin system in human and monkey ovaries: in situ gene expression of the different componentsH Karam, O Valdenaire, M F Belair, et al.Journal of Cardiovascular Pharmacology|January 1, 1996
Up-regulation of endothelin-B receptors in atherosclerotic human coronary arteriesP H Dagassan, V Breu, M Clozel, et al.The Journal of Pharmacology and Experimental Therapeutics|July 20, 1999
Pharmacology of tezosentan, new endothelin receptor antagonist designed for parenteral useM Clozel, H Ramuz, J P Clozel, et al.Journal of Cardiovascular Pharmacology|September 1, 1991
Effect of the renin response during renin inhibition: oral Ro 42-5892 in normal humansE Camenzind, J Nussberger, L Juillerat, et al.Pageof 13